We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Ten years have passed since Pfizer’s glaucoma drug ...

We write in response to Mr Dubois and Ms Titcomb regarding the controversy over the switch from Xalatan to generic latanoprost. 1, 2 We prospectively studied our patients’ experience and the impact of ...

Jan. 2, 2003 -- The U.S. Food and Drug Administration (FDA) has approved the once-daily prescription eye drop latanoprost (Xalatan) as an initial treatment for elevated intraocular pressure (IOP) ...

Latanoprost is a generic prescription medication. The Food and Drug Administration (FDA) has approved it to treat increased pressure in the eyes. The drug is for use in adults who have either ...

Please provide your email address to receive an email when new articles are posted on . LONDON — Latanoprost (Xalatan; Pharmacia Corporation) monotherapy once daily can be an alternative to combined ...

Peapack, New Jersey (May 2, 2002) - Data presented for the first time at the XXIXth International Congress of Ophthalmology in Sydney, Australia, show that long-term (5-year) adjunctive treatment with ...

Investing.com -- Glenmark Pharmaceuticals (NSE:GLEN) Inc., USA has launched the Latanoprost Ophthalmic Solution, 0.005% (0.05 mg/mL), a product that is bioequivalent and therapeutically equivalent to ...

Fort Lauderdale, Florida (May 8, 2002) – Switching to XALATAN® (latanoprost ophthalmic solution) once daily from monotherapy with other medications, including prostaglandin derivatives, for open angle ...

Case 1 A 73-year-old lady with primary open-angle glaucoma had therapeutic failure with several antiglaucoma medications. In view of inadequate control of intraocular pressure and undesirable side ...

VANCOUVER, British Columbia, Aug. 29, 2011 (GLOBE NEWSWIRE) -- QLT Inc. /quotes/zigman/13615/quotes/nls/qlti QLTI +1.81% /quotes/zigman/13629 CA:QLT +1.99% today ...